Lung Yi Mak
www.mendeley.com
0000-0002-2266-3935
6 papers found
Refreshing results…
SGLT2i reduces risk of developing HCC in patients with co-existing type 2 diabetes and hepatitis B infection: A territory-wide cohort study in Hong Kong
Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines
Editorial: liver and kidney injury from remdesivir—an issue not as much as its purpose. Authors' reply
Magnetic resonance imaging metrics and the predictability of adverse outcomes in on‐treatment Asian chronic hepatitis B
Remdesivir use and risks of acute kidney injury and acute liver injury among patients hospitalised with COVID ‐19: a self‐controlled case series study
On‐treatment gamma‐glutamyl transferase predicts the development of hepatocellular carcinoma in chronic hepatitis B patients
Missing publications? Search for publications with a matching author name.